Tobam Has $4.56 Million Holdings in Humana Inc. $HUM

Tobam increased its position in Humana Inc. (NYSE:HUM) by 108.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,664 shares of the insurance provider’s stock after buying an additional 9,698 shares during the period. Humana accounts for approximately 1.8% of Tobam’s investment portfolio, making the stock its 18th biggest holding. Tobam’s holdings in Humana were worth $4,563,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Humana by 16.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock valued at $300,728,000 after acquiring an additional 158,528 shares in the last quarter. Focus Partners Wealth increased its position in shares of Humana by 104.2% during the 1st quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock valued at $1,701,000 after purchasing an additional 3,281 shares during the last quarter. Circle Wealth Management LLC bought a new stake in shares of Humana during the 1st quarter worth $425,000. Kera Capital Partners Inc. purchased a new position in shares of Humana in the 2nd quarter worth about $253,000. Finally, Voya Investment Management LLC grew its position in Humana by 7.7% during the first quarter. Voya Investment Management LLC now owns 45,190 shares of the insurance provider’s stock valued at $11,957,000 after buying an additional 3,221 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on HUM shares. Bank of America lifted their price objective on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. Piper Sandler dropped their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research note on Thursday, July 31st. Mizuho increased their price objective on Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Truist Financial lowered their target price on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research note on Monday. Finally, Evercore ISI assumed coverage on Humana in a report on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price objective for the company. Eight investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $298.39.

Humana Trading Up 2.1%

Shares of HUM stock opened at $243.52 on Wednesday. The business has a 50-day moving average price of $275.39 and a two-hundred day moving average price of $258.51. The firm has a market cap of $29.29 billion, a P/E ratio of 18.69, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The firm had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same period last year, the firm posted $4.16 earnings per share. The business’s revenue was up 11.1% compared to the same quarter last year. Equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.5%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is presently 33.18%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.